Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Détails

ID Serval
serval:BIB_9F2C7865C7CF
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Titre
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.
Périodique
The British journal of radiology
Auteur(s)
Cacicedo J., Navarro A., Del Hoyo O., Gomez-Iturriaga A., Alongi F., Medina J.A., Elicin O., Skanjeti A., Giammarile F., Bilbao P., Casquero F., de Bari B., Dal Pra A.
ISSN
1748-880X (Electronic)
ISSN-L
0007-1285
Statut éditorial
Publié
Date de publication
11/2016
Peer-reviewed
Oui
Volume
89
Numéro
1067
Pages
20160217
Langue
anglais
Notes
Publication Status: ppublish
Publication types: Journal Article
Publication types: Journal Article ; Review

Résumé
Squamous cell carcinoma is the most common malignant tumour of the head and neck. The initial TNM staging, the evaluation of the tumour response during treatment, and the long-term surveillance are crucial moments in the approach to head and neck squamous cell carcinoma (HNSCC). Thus, at each of these moments, the choice of the best diagnostic tool providing the more precise and larger information is crucial. Positron emission tomography with fluorine-18 fludeoxyglucose integrated with CT ((18)F-FDG-PET/CT) rapidly gained clinical acceptance, and it has become an important imaging tool in routine clinical oncology. However, controversial data are currently available, for example, on the role of (18)F-FDG-PET/CT imaging during radiotherapy planning, the prognostic value or its real clinical impact on treatment decisions. In this article, the role of (18)F-FDG-PET/CT imaging in HNSCC during pre-treatment staging, radiotherapy planning, treatment response assessment, prognosis and follow-up is reviewed focusing on current evidence and controversial issues. A proposal on how to integrate (18)F-FDG-PET/CT in daily clinical practice is also described.

Mots-clé
Carcinoma, Squamous Cell/diagnostic imaging, Carcinoma, Squamous Cell/pathology, Carcinoma, Squamous Cell/radiotherapy, Fluorodeoxyglucose F18, Head and Neck Neoplasms/diagnostic imaging, Head and Neck Neoplasms/pathology, Head and Neck Neoplasms/radiotherapy, Humans, Neoplasm Staging, Positron Emission Tomography Computed Tomography, Prognosis, Radiopharmaceuticals, Radiotherapy Planning, Computer-Assisted, Radiotherapy, Image-Guided
Pubmed
Création de la notice
01/11/2016 20:45
Dernière modification de la notice
03/03/2018 20:02
Données d'usage